Researchers are developing new drugs to broaden the options for available therapies, offering hope for individuals with Attention Deficit Hyperactivity Disorder (ADHD) who may not respond well to traditional stimulant medications.
Non-Stimulant Medication Developments
Two non-stimulant medications are advancing in development, providing alternative treatment options for ADHD. These medications work differently than stimulants, targeting different pathways in the brain to alleviate symptoms.
New developments in non-stimulant medications offer hope for individuals with ADHD. Learn more about the latest research and advancements.
Genetics Research and Physical Health Risks
Genetics research has linked ADHD with physical health risks, highlighting the importance of comprehensive care. Select programs and policies are moving forward to address these concerns and improve outcomes for individuals with ADHD.
Research reveals that non-stimulant medications can be an effective alternative for individuals with ADHD who do not respond well to traditional stimulant medications.
Laura Lurns · Learning Success expert
Nationwide Recall and Symptom Control
A nationwide recall may affect symptom control for some individuals with ADHD, emphasizing the need for careful medication management and alternative treatment strategies.
Key takeaways
- Non-Stimulant Medications: Two new medications are in development, offering alternative treatment options for ADHD. Genetics Research: Links ADHD with physical health risks, emphasizing the need for comprehensive care. Nationwide Recall: May affect symptom control, highlighting the importance of careful medication management.
Looking Ahead
As research continues to uncover the complexities of ADHD, new developments in non-stimulant medications and comprehensive care approaches offer promise for improved treatment outcomes and enhanced quality of life for individuals with ADHD.
By embracing these advancements and working together, we can create a brighter future for individuals with ADHD, one that is filled with hope, understanding, and support. The Learning Success All Access Program offers a free trial, including a personalized Action Plan that you keep even if you decide it’s not the right fit.
See what All Access gives your child
Explore Focus Foundations
Is your child struggling in school?
Get your free personalized learning roadmap
You describe what you see at home. We turn it into a plan you start this week.
- Answer 5 short questionnaires about what you already notice, 30–45 minutes at your own kitchen table
- Your child sits no test and gets no score: nothing to schedule, nothing for them to dread
- You do the answering, the AI does the writing, and a person reviews it before it reaches you
- Access all 40+ courses instantly: reading, math, focus, processing and more, with new ones added regularly
Why we use AI, plainly: it writes from a knowledge base our team maintains and audits. We work through it line by line and pull anything the evidence stops supporting. The roadmap you get on Tuesday reflects what we corrected on Monday, and a human still reads it before you do.
Your school district must evaluate your child free of charge if you ask in writing, whatever your income and whatever the outcome (US, 34 CFR 300.111 and 300.301(b)). That route takes time and answers a different question than you do. This one starts today, from what you already know.
Your answers stay yours. We do not sell your personal information, and we do not hand identifiable assessment data to outside AI companies to train their models.
A screener is a starting point, not a diagnosis. If your child might need formal accommodations (an IEP or 504 plan), or you suspect a vision, hearing or medical cause, pursue a professional evaluation too. That is the only route to those supports.
References
